Henry Thomason, MD
Orthopaedic Surgery · Gastonia, NCNPI 1841266301
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $36,988 of the $57,446 with a category attached, or 64.4%. Heron Therapeutics, Inc. accounts for 88.9% of it on its own, with 29 other manufacturers making up the rest. 2025 is the largest year on record at $23,587, 8.0 times the $2,953 reported in 2019.
Across 140 payments — averaging $410.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heron Therapeutics, Inc.$51K
- Zimmer Biomet$4K
- Johnson & Johnson$678
- Stryker$565
- Peerless Surgical Inc.$314
- Fidia Pharma USA Inc.$175
- plus $1K from 24 others
Across 25 payments — averaging $4285.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$107K
What the payments were for
- Consulting fees$7,87414%
- Speaking & faculty fees$36,98864%
- Travel & lodging$8,23314%
- Food & beverage$4,3528%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heron Therapeutics, Inc. | 44 | $51,059 |
| Zimmer Biomet | 15 | $3,555 |
| Johnson & Johnson(2 entities) | 15 | $678 |
| Stryker | 12 | $565 |
| Peerless Surgical Inc. | 3 | $314 |
| Fidia Pharma USA Inc. | 6 | $175 |
| Pacira Therapeutics, Inc. | 8 | $173 |
| Radius Health, Inc. | 6 | $144 |
| Orthalign Inc | 1 | $114 |
| Medical Device Business Services, Inc. | 2 | $109 |
| Medtronic | 1 | $95 |
| Sanofi-aventis U.S. LLC | 2 | $55 |
| Heraeus Medical, LLC. | 4 | $53 |
| Convatec Inc. | 3 | $44 |
| Smith+Nephew | 2 | $37 |
| Ferring Pharmaceuticals Inc. | 2 | $34 |
| Myoscience Inc. | 1 | $32 |
| Vertex | 1 | $28 |
| Dynasplint Systems Inc. | 1 | $26 |
| ERMI LLC | 1 | $19 |
| Kinex Medical Company LLC | 1 | $18 |
| Bioventus LLC | 1 | $17 |
| Forte Bio-pharma LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Baxter Healthcare | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
| Molnlycke Health Care US, LLC | 1 | $12 |
| Pfizer | 1 | $12 |
| Ossur Americas, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zynrelef$50,575
- APONVIE$8,981
- Surgical Product Portfolio$1,375
- Surgical Instruments$625
- PI Surgical$500
- ZIPSEAL 16 SURGICAL SKIN CLOSURE KIT$354
- Persona$280
- G7$144
- mymobility Platform$132
- ORTHALIGN PLUS$114
How this compares
$57,446 in reported general payments places this provider in the 85th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 782 | $5,559 |
| EliquisApixaban | 11 | $4,138 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 191 | $2,079 |
| Cefadroxil | 212 | $1,036 |
| Celecoxib | 60 | $694 |
| Amoxicillin | 240 | $444 |
| Mupirocin | 46 | $415 |
| Clindamycin Hcl | 96 | $320 |
| Methylprednisolone | 57 | $313 |
| Tramadol Hcl | 96 | $273 |
| Ondansetron Hcl | 37 | $217 |
| Diclofenac Sodium | 21 | $213 |
| Hydromorphone Hcl | 23 | $191 |
| Ondansetron OdtOndansetron | 22 | $182 |
| Meloxicam | 118 | $161 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $12 | $4,13811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 845 orthopaedic surgery providers in North Carolina.
Other orthopaedic surgery in Gastonia
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- William JiranekDurham$6.4M
- John MasonCharlotte$5.7M
- Thomas VailDurham$5.7M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$4.9M
- Mark EasleyDurham$4M
- Carroll JonesCharlotte$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.